Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Respiratory Syncytial Suppliers In Europe
14 companies found
based inSultanbeyli – Istanbul, TURKEY
Anatolia Geneworks is a biotechnology company operating in accordance with ISO 9001, ISO 13485 and 98/79/EC Total Quality Systems. The main activities of Anatolia Diagnostics and Biotechnology Inc. are to develop and manufacture Real-Time Polymerase ...
Respiratory tract infections are typically divided into upper and lower respiratory tract infections which occur mainly in the nose, throat affecting upper respiratory system, windpipe, airways and lungs affecting lower respiratory system. From ...
based inGaithersburg, MARYLAND (USA)
We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. We have more than a decade of experience contending with ...
With the ongoing development of our NanoFlu™ and RSV F vaccines, a strong rationale exists for developing a combination respiratory vaccine that is designed to protect susceptible populations against both diseases. Although testing is at an ...
based inSan Mateo de Gállego Zaragoza, SPAIN
CerTest Biotec, S.L. is an independent biotechnology company devoted to the development and manufacturing of IVD diagnostic products in human clinical field. An innovative technology-based company whose success lies in its human capital, highly ...
CerTest Influenza A+B+RSV one step combo card test is a coloured chromatographic immunoassay for the simultaneous qualitative detection of Influenza type A and type B and Respiratory Syncytial Virus antigens from ...
based inCambridge, UNITED KINGDOM
Our business is organised to deliver our strategic priorities sustainably, supporting continued scientific innovation and commercial success. We focus on the discovery, development and commercialisation of prescription medicines in Oncology and ...
IVX-A12 is a bivalent combination of IVX-121 and IVX-241, a human metapneumovirus (hMPV) VLP vaccine candidate. IVX-A12 is being designed to target both RSV and hMPV in a single vaccine candidate. hMPV is being increasingly recognized as a major ...
based inBirmingham, ALABAMA (USA)
BioGX, Inc. is a global molecular diagnostics company that has been focused on the health and safety of communities all over the world from its inception in 2007, originally developing tests for Water Quality, Food Safety and Pharma Quality Control. ...
The test is offered in BioGX’s trusted, easy to use Sample-Ready™ format where all required reagents for real-time PCR are lyophilized in a single tube. BioGX provided tube snaps into a test-specific position on the BD MAX™ total ...
based inSchlieren, SWITZERLAND
Virometix is a clinical stage biotech company pioneering a new class of synthetic vaccines to tackle infectious diseases and cancer. Our structure-based vaccines are designed to direct a precise, robust and sustained immune response. With a ...
Respiratory syncytial virus (RSV) is a prevalent, contagious respiratory pathogen, the leading cause of bronchitis and pneumonia, affecting more than 64 million people each year worldwide. In ...
based inTübingen, GERMANY
Founded in 2015, Atriva Therapeutics is a biopharmaceutical company specifically pioneering the development of host-targeting antiviral therapies set up by a team of leading scientists in viral research and seasoned industry experts. The company ...
The company’s lead drug candidate is the MEK inhibitor zapnometinib. The small molecule, which can be administered orally (tablet), is under advanced clinical development in two severe respiratory viral diseases: COVID-19 and influenza, two ...
based inDublin, IRELAND
Our mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life. We offer a full range of consulting, clinical development and commercialisation services from a global network of offices in ...
Focused on the unique needs of device and diagnostics manufacturers, ICON has broad experience in supporting trials of respiratory disease and infectious disease affecting respiratory function. The prevalence of respiratory diseases will continue to ...
based inCuarte de Huerva (Zaragoza), SPAIN
OPERON was established 1973 as a private R&D laboratory in the field of immunochemistry. Initially, the target of the company was to satisfy the needs of the Spanish market. Three years later, the strategy changed focusing on the international ...
A single-step immunochromatographic test for the qualitative detection of respiratory Adenovirus in nasopharyngeal swab, wash, and aspirate respiratory samples. Adenovirus is a virus with double-stranded DNA, non-enveloped, belonging to the ...
based inNeuried, GERMANY
Together, we drive innovation in molecular diagnostics! Our team of highly skilled chemists, biologists and physicists with extensive experience in developing molecular technologies is dedicated to improve fast diagnostics and further develop our ...
Differentiate between FLU A/B and relevant respiratory pathogens. res4plex direct RT-PCR is uniquely designed to detect Influenza A,InfluenzaB as well as SARS-CoV-2 and human respiratory syncytial ...
based inRotkreuz, SWITZERLAND
Roche Diagnostics is a division of Roche. We develop and integrate diagnostic solutions that address the challenges of today and anticipate the needs of tomorrow. In more than 100 countries, we offer the industry’s most comprehensive in vitro ...
GenMark Diagnostics is committed to meeting customer needs with a broad menu of multiplex molecular products. The products presented in this section are available only in the U.S. at this ...
based inSydney, AUSTRALIA
SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. SpeeDx is a dynamic, rapidly growing company with a strong portfolio of technology at the ...
based inLondon, UNITED KINGDOM
Founded in 2015, the original idea behind Airfinity was to systematically capture and structure the new science disseminated at conferences, a highly fragmented dataset. However, through working with medical associations and pharma companies, ...
based inLublin, POLAND
BioMaxima S.A. is a Polish company listed on GPW Main Market, producer of microbiology media as well as a wide range of reagents and in vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics ...
The growing requirements of the market, especially as regards the time of sample testing, accuracy of the method and workload, made BioMaxima S.A. set itself the goal of creating products that meet this demand. The BioMaxima S.A. offer has been ...